Manufacturing & Lab Equipment
Regulatory, Tech Transfer & Support Services
Company Overview
About
IGS B.V. is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Respiratory
Allergy
Quick Facts
HQ:Netherlands
Founded:2017
Employees:368
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Sterile Injectable
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
Global
Regulatory Approvals
Drug Approval CGG6VQ
FDA · #APR-10V34ZYJ · 2022-08-01
Drug Approval 6XVU39
Health Canada · #APR-XDTFJXAN · 2018-02-01
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-U595HV6O
Issued: 2020-09-12
Expires: 2025-03-18
WHO GMP
World Health Organization
Cert #: CERT-845W1KMY
Issued: 2020-06-02
Expires: 2025-04-26
Loading CDMO intelligence...
Key facts about IGS B.V.
- IGS B.V. is headquartered in the Netherlands.
- IGS B.V. was founded in 2017.
- IGS B.V. has 368 employees.
- IGS B.V.'s capabilities include Biologics Drug Substance, Biologics Manufacturing and Formulation Development.
Find CDMOs like IGS B.V.
Directory pages this company appears in, each with the full list of matching manufacturers.